These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37533272)

  • 1. [Arguments justifying the measurement of the most relevant biochemical parameters to monitor bone and mineral metabolism in dialysis patients].
    Ureña Torres PA; Jean G
    Nephrol Ther; 2023 Aug; 19(4):293-296. PubMed ID: 37533272
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineral and bone disorder in chronic kidney disease: pioneering studies.
    Floege J; Drüeke TB
    Kidney Int; 2020 Oct; 98(4):807-811. PubMed ID: 32998807
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of bone remodeling: impact of novel therapies.
    Hercz G
    Semin Dial; 2001; 14(1):55-60. PubMed ID: 11208041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. III. Clinical algorithms on renal osteodystrophy.
    Nephrol Dial Transplant; 2000; 15 Suppl 5():39-57. PubMed ID: 11073276
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Soohoo M; Obi Y; Rivara MB; Adams SV; Lau WL; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Arah OA; Mehrotra R; Streja E
    Am J Nephrol; 2022; 53(2-3):157-168. PubMed ID: 35226895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of mineral metabolism in CAPD patients.
    Delmez JA
    Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
    Slatopolsky E
    Kidney Int; 1987 Mar; 31(3):842-54. PubMed ID: 3573543
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
    Weissheimer R; Bucharles SGE; Truyts CAM; Jorgetti V; Figueiredo AE; Barrett P; Olandoski M; Pecoits-Filho R; Moraes TP
    J Bras Nefrol; 2021; 43(2):173-181. PubMed ID: 33538758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series.
    Zamoner SMS; Takase HM; Riyuzo MC; Caramori JCT; de Andrade LGM
    Int Urol Nephrol; 2024 May; 56(5):1669-1676. PubMed ID: 37964112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal bone disease.
    Cundy TF; Kanis JA
    Br J Hosp Med; 1985 Jan; 33(1):35-40. PubMed ID: 3882177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the influence of dialysis with varying bath calcium concentrations on the different plasma calcium fractions.
    Verberckmoes R
    Klin Wochenschr; 1972 May; 50(9):480-2. PubMed ID: 5043471
    [No Abstract]   [Full Text] [Related]  

  • 17. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
    Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
    Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
    Laster M; Soohoo M; Streja E; Elashoff R; Jernigan S; Langman CB; Norris KC; Salusky IB; Kalantar-Zadeh K
    Pediatr Nephrol; 2019 Jan; 34(1):107-115. PubMed ID: 30267239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dialysis bone disease in children. Six cases (author's transl)].
    Luciani JC; Ferran JL; Dumas ML; Meunier P; Dumas R
    Nouv Presse Med; 1977 Nov; 6(39):3616-9. PubMed ID: 607175
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone mineral density in patients on maintenance dialysis.
    Ambrus C; Marton A; Nemeth ZK; Mucsi I
    Int Urol Nephrol; 2010 Sep; 42(3):723-39. PubMed ID: 20039127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.